CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-07 | Nicholson John SVP & Chief Operating Officer | Sale | −101,700 | $19.24 | $2.0M | 227,243 |
| 2017-06-07 | Nicholson John SVP & Chief Operating Officer | Exercise or conversion · Stock Option | −150,000 | 0 | ||
| 2017-05-16 | Thomsen Jillian B. SVP & Chief Accounting Officer | Sale | −2,651 | $19.55 | $52K | 52,986 |
| 2017-05-16 | ROBIN HOWARD W President & CEO | Sale | −8,388 | $19.55 | $164K | 160,884 |
| 2017-05-16 | Nicholson John SVP & Chief Operating Officer | Sale | −3,146 | $19.55 | $62K | 178,943 |
| 2017-05-16 | Labrucherie Gil M SVP & Chief Financial Officer | Sale | −3,179 | $19.55 | $62K | 66,091 |
| 2017-05-16 | Hora Maninder SVP Pharma Dev & Mfg Ops | Sale | −2,959 | $19.55 | $58K | 60,689 |
Page 43 of 43 · 847 trades